trial · primary record
BNT3219
Advanced Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 207 |
| Primary completion | 2030-10 |
| Primary endpoint | Occurrence of dose-limiting toxicities (dose escalation only) |
| Registry ID | NCT07893054 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:29.410Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07893054
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.